Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2010-06-07

Clinical Trial Update: Montelukast in Perennial Allergic Rhinitis - 2001-2002 Study (0476-246) [Phase 3]

View source ↗

Summary

Phase 3 trial assessing montelukast for perennial allergic rhinitis has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Montelukast (Montelukast)

Snippet

Sponsor: Organon and Co | Conditions: Perennial Allergic Rhinitis | Phase 3 | Status: COMPLETED | Results posted: 2010-06-07